Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers are being identified with more frequency, so all tumor markers may not yet be reflected on this list.
- Aldehyde Dehydrogenase 1 (ALDH1)
- Apolipoprotein A-I (apoA-I)
- Bikunin
- Carbohydrate Antigen 125 (CA125)
- Creatine Kinase B (CKB)
- Cu Isotope
- Exosomes
- Folate Receptor Alpha (FOLR1)
- Glutathione S-Transferase Polymorphisms (GSTP)
- Human Epididymis Protein 4 (HE4)
- Kallikreins (KLKs)
- Mesothelin
- mRNA and incRNA
- Osteopontin (OPN)
- Programmed death ligand 1 (PD-L
- Prostasin (PSN)
- Transferrin
- Transthyretin (TTR)
- Vascular Endothelial Growth Factor (VEGF)